Characteristics of participants | ||||
---|---|---|---|---|
Groups | All | CUSb | CI-Vc | CI-NVd |
Sample size (n (%)) | 425 (100 %) | 243 (57.2 %) | 116 (27.3 %) | 66 (15.5 %) |
Sex female (n (%)) | 315 (74.1 %) | 172 (70.8 %) | 88 (75.9 %) | 55 (83.3 %) |
Age (Mean ± SD) | 83.6 ± 8.8 | 82.5 ± 9.4 | 84.4 ± 7.8 | 86.1 ± 7.5* |
Level of care (Median of range 1–7) | 5 | 4* | 5 | 5 |
Length of stay in months (Mean ± SD) | 29.7 ± 23.9 | 27.8 ± 20.8 | 31.2 ± 27.8 | 34.5 ± 26.3 |
Number of diseases (Mean ± SD) | 7,4 ± 4.3 | 8,0 ± 4.7* | 6.8 ± 4.0 | 6.5 ± 3.2 |
Disease categories (n (%)) | ||||
Cardiology | 305 (73.3 %) | 179 (76.2 %) | 83 (72.2 %) | 43 (65.2 %) |
Neurology | 295 (70.9 %) | 145 (61.7 %)* | 91 (79.1 %) | 59 (89.4 %) |
Endocrinology | 228 (54.8 %) | 133 (56.6 %) | 64 (55.7 %) | 31 (47.0 %) |
Orthopedics | 204 (49.0 %) | 128 (54.5 %)* | 46 (40.0 %) | 30 (45.5 %) |
Subgroups of ‘Red Diagnoses’ (n(%)a) | ||||
Injuries and trauma sequelae | 108 (49.1 %) | 67 (48.6 %) | 27 (54.0 %) | 14 (43.8 %) |
Arthrosis | 74 (33.6 %) | 50 (36.2 %) | 13 (26.0 %) | 11 (34.4 %) |
Disorders of spine and extremities | 67 (30.5 %) | 49 (35.5 %) | 11 (22.0 %) | 7 (21.9 %) |
Neuropathic | 22 (10.0 %) | 15 (10.9 %) | 4 (8.0 %) | 3 (9.4 %) |
Number of prescriptions scheduled permanently (PP) (Mean ± SD) | 9.0 ± 3.9 | 9.7 ± 3.9 | 8.8 ± 3.9 | 6.8 ± 3.2* |